Katharina Gitmann-Kopilevich
Certified specialist in IP law focusing on infringement and urgent proceedings as well as pharmaceutical and food law – entitled to represent clients before all divisions of the Unified Patent Court.
- Representation before all UPC divisions
- Attorneys-at-law and patent attorneys
- Reply usually within 24 hours

Katharina Gitmann-Kopilevich
Specialist Attorney for Intellectual Property
Career
Katharina Gitmann-Kopilevich studied law at Leibniz University Hanover and the University of Hamburg. After her legal traineeship, including at the Hamburg Senate Chancellery, she was a research associate at a media law firm. She has been a lawyer at the firm since 2016 and a certified specialist in IP law since 2018.
Role in the UPC team
Katharina Gitmann-Kopilevich conducts infringement and urgent proceedings, in particular for clients in pharma, medical technology, cosmetics and consumer goods. She prepares protective letters and represents clients in proceedings involving pharmaceutical and food law. As a lawyer admitted in Germany, she is entitled to represent clients before all UPC divisions under Art. 48(1) UPCA.
Focus areas
- Patent infringement and provisional measures
- Pharma, generics, biosimilars, medical technology
- Pharmaceutical, food and cosmetics law
- Unfair competition and trade mark law
Languages
German, English, Russian
Case examples
Typical situations we encounter in our advisory work – anonymised and simplified.
Supporting a generic launch
Typical case: for a generic manufacturer, she prepares protective letters and a revocation action before the product is launched.
Urgent proceedings in medical technology
Typical case: with her help, a manufacturer of wound care products obtains a provisional order against an imitator.
Cosmetics patent
Typical case: a patent on an emulsion formulation is infringed. She coordinates laboratory analyses of the infringing products as evidence.
Russian-speaking clients
Typical case: for a client with sales in Eastern Europe, she handles communication in Russian and examines the situation in the Baltic UPC states.
Bolar exemption
Typical case: a biotech company is attacked over regulatory trials. She successfully invokes the experimental use and Bolar exemptions.
Your UPC team: authorised to represent before the Unified Patent Court
Michael Horak, Julia Ziegeler, Stefan Karfusehr, Robin Jannis Mai, Anna Umberg, Katharina Gitmann-Kopilevich, Karoline Behrend and Andreas Friedlein are attorneys-at-law admitted in Germany and are therefore entitled under Art. 48(1) UPCA to represent clients before all divisions of the Unified Patent Court and before the Court of Appeal in Luxembourg. Our patent attorneys contribute the technical expertise.
Dipl.-Ing. Michael Horak, LL.M.Attorney-at-law · Partner · Consulting Engineer✓ UPC representation
Julia ZiegelerAttorney-at-law · Partner✓ UPC representation
Stefan KarfusehrAttorney-at-law✓ UPC representation
Robin Jannis Mai, LL.B.Attorney-at-law✓ UPC representation
Anna Umberg, LL.M., M.A.Attorney-at-law✓ UPC representation
Katharina Gitmann-KopilevichAttorney-at-law✓ UPC representation
Karoline BehrendAttorney-at-law✓ UPC representation
Andreas FriedleinAttorney-at-law✓ UPC representationFrequently asked questions
Does Ms Gitmann-Kopilevich also handle regulatory approval issues?
Yes, at the interface of patent and pharmaceutical law, for example for generics and biosimilars.
Related topics
Deadlines are running – we review your case at short notice
Statement of defence, appeal, protective letter or opt-out: many steps before the Unified Patent Court are subject to strict deadlines. Tell us about your case – confidentially and under attorney-client privilege.
Head office Hanover: 0511 35 73 56-0
info@upc-anwalt.de
10 offices in Germany · advice also by video call
As of November 2026. This information is provided for general guidance only and does not replace legal advice in an individual case. Legal bases: Agreement on a Unified Patent Court (UPCA), Rules of Procedure of the UPC (RoP), Regulations (EU) No 1257/2012 and 1260/2012, German Patent Act, German Utility Model Act, EPC, PCT.
